KFS
MED icon

Kelly Financial Services’s Medifast MED Stock Holding History

Kelly Financial Services’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2
Closed -$50 – 491
2024
Q2 		$50 Hold
2
– – ﹤0.01% 771
2024
Q1 		$88 Hold
2
– – ﹤0.01% 768
2023
Q4 		$154 Hold
2
– – ﹤0.01% 743
2023
Q3 		$167 Hold
2
– – ﹤0.01% 724
2023
Q2 		$202 Hold
2
– – ﹤0.01% 684
2023
Q1 		$224 Hold
2
– – ﹤0.01% 656
2022
Q4 		$245 Hold
2
– – ﹤0.01% 634
2022
Q3 		$227 Hold
2
– – ﹤0.01% 645
2022
Q2 		$374 Hold
2
– – ﹤0.01% 618
2022
Q1 		$350 Hold
2
– – ﹤0.01% 628
2021
Q4 		$426 Hold
2
– – ﹤0.01% 632
2021
Q3 		$390 Hold
2
– – ﹤0.01% 611
2021
Q2 		$570 Hold
2
– – ﹤0.01% 587
2021
Q1 		$424 Buy
+2
New +$479 ﹤0.01% 589

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kelly Financial Services's MED Position: Q3 2024 in Review

Kelly Financial Services sold out of Medifast (MED) in Q3 2024, closing a stake of 2 shares — an estimated $50 sold.

Kelly Financial Services first reported a position in MED in Q1 2021 and held it in 14 quarters. The position peaked at $570 in Q2 2021. 140 funds tracked by Wall St. Rank hold MED as of Q3 2024.

  • Kelly Financial Services reported no remaining Medifast position as of Q3 2024 after selling out during the quarter.
  • Kelly Financial Services sold 2 Medifast shares in Q3 2024, an estimated $50.
  • Kelly Financial Services first reported a position in Medifast in Q1 2021 and held it in 14 quarters.
  • Kelly Financial Services's Medifast position peaked at $570 in Q2 2021.
  • 140 funds tracked by Wall St. Rank held Medifast as of Q3 2024.

Based on Kelly Financial Services's 13F filing for Q3 2024, filed 9 Oct 2024.